The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

G Rammes; B Mahal; J Putzke; C Parsons; P Spielmanns; E Pestel; R Spanagel; W Zieglgänsberger; J Schadrack

doi:10.1016/s0028-3908(01)00008-9

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

Identifier:nobleid.org/w1/20260515/D91EB61B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D91EB61B.svg?ark=w1%2F20260515%2FD91EB61B)](https://nobleid.org/work/w1/20260515/D91EB61B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

Identifier:nobleid.org/w1/20260515/D91EB61B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D91EB61B.svg?ark=w1%2F20260515%2FD91EB61B)](https://nobleid.org/work/w1/20260515/D91EB61B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work